Media Contact Dan Budwick¿Pure Communications, Inc.¿(973) 271-6085 email@example.comInvestor ContactMark MullikinEditas Medicine, Inc.(617) firstname.lastname@example.org
CAMBRIDGE, Mass., Nov. 09, 2016 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (NASDAQ:EDIT), a leading genome editing company, today announced that it will present a company overview at the Stifel Healthcare Conference 2016 on Wednesday, November 16, 2016, at 10:15 a.m. ET in New York City. A live webcast of the presentation will be available on the Investors & Media section of the Editas website at www.editasmedicine.com. An archived replay will be available for approximately 30 days following the presentation. About Editas MedicineEditas Medicine is a leading genome editing company dedicated to treating patients with genetically-defined diseases by correcting their disease-causing genes. The company was founded by world leaders in genome editing, and its mission is to translate the promise of genome editing science into a broad class of transformative genomic medicines to benefit the greatest number of patients.